PerkinElmer Welcomes Dr. Kaveh Kahen as Head of Analytical & Testing Solutions

PerkinElmer Appoints Dr. Kaveh Kahen

PerkinElmer, a prominent name in analytical and testing solutions, has announced the appointment of Dr. Kaveh Kahen as President of its Analytical & Testing Solutions (ATS) business. Dr. Kahen returns to PerkinElmer, bringing over two decades of extensive experience in both leadership and technical roles within the life sciences and analytical technologies sectors.

A Wealth of Experience

Previously, Dr. Kahen held key leadership positions, including President of both Danaher’s Abcam and Phenomenex businesses. At Abcam, he led efforts to implement a unified digital platform across the company's global locations, setting a strong data foundation for AI-assisted antibody development. His tenure at Phenomenex was marked by renewed growth, as he spearheaded innovative product development and propelled digital modernization initiatives.

Michael Stubblefield, the CEO of PerkinElmer, emphasized Dr. Kahen's exceptional blend of technical knowledge and commercial acumen, declaring him well-suited to guide ATS toward its next growth chapter. Kahen's immediate objectives will be to accelerate product development, enhance laboratory workflows with AI-driven technologies, and bolster service offerings throughout the lifecycle of PerkinElmer's instruments.

Innovations Ahead

This leadership transition comes at an exciting time for the Analytical & Testing Solutions sector, following a year filled with significant innovations. Recent advancements include the launch of the Avio® 3000 ICP-OES, the redesigned Clarus® Nova GC, and the Spotlight™ Aurora-I FTIR microscope. Additionally, the rollout of LabPilot™, a comprehensive digital platform that integrates PerkinElmer's instruments and software services, marks a leap forward in creating connected environments for laboratory users.

Dr. Kahen expressed enthusiasm about rejoining PerkinElmer, recognizing the company's remarkable legacy in analytical science, which spans nearly 90 years of innovation in instrumentation and engineering. He sees immense potential in merging this solid foundation with cutting-edge technologies such as AI, automation, and advanced software, aiming to build more intelligent and connected laboratory environments.

A Proven Track Record

Dr. Kahen’s background includes serving as CEO and Board Member of Advion Interchim Scientific, alongside co-founding Sigma Analytical Services where he assumed various leadership roles. His prior experience at PerkinElmer includes positions such as Senior Director of Global R&D and VP & General Manager of the mass spectrometry segment. Notably, he earned his Ph.D. in Analytical Chemistry from The George Washington University and holds ten U.S. patents, many of which continue to impact PerkinElmer’s innovative technologies.

As Dr. Kahen steps into this pivotal role, his vision for the future of the Analytical & Testing Solutions sector promises to harness the power of technology in advancing scientific research and operational efficiencies. PerkinElmer, known for its commitment to providing insights that uphold safety and quality across various critical sectors—from healthcare to environmental sustainability—is poised to thrive under his leadership, reinforcing its stature as a global leader in analytical solutions.

Conclusion

In a world increasingly driven by innovation, Dr. Kahen’s return to PerkinElmer heralds a transformative phase for the Analytical & Testing Solutions business. With a focus on integrating technology and fostering collaboration with customers, the future looks bright for PerkinElmer as it navigates the challenges of the ever-evolving scientific landscape.